doi:10.1016/S0140-6736(19)31149-3
About the author Maia Anderson Maia Anderson is a senior reporter at Healthcare Brew, where she focuses on pharma developments like GLP-1s and psychedelic medicine, pharmacies, and women's health.
Klausen MK, Knudsen GM, Vilsbll T, Fink-Jensen A (2025) Effects of GLP-1 Receptor Agonists in Alcohol Use Disorder
How much does semaglutide cost if my dose increases to the maximum
Stopping and rebound
Modifying factors in the association between GLP-1RAs and cancer risk The section primarily reviews the various factors influencing the cancer risk associated with GLP-1RAs, including patient characteristics, comorbidities, clinical treatment, and lifestyle